Insider Transactions in Q3 2019 at Turning Point Therapeutics, Inc. (TPTX)
Insider Transaction List (Q3 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2019
|
Glaxosmithkline PLC Director |
BUY
Open market or private purchase
|
Indirect |
177,777
+7.57%
|
$7,999,965
$45.0 P/Share
|
|
Sep 10
2019
|
Athena Countouriotis President & CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+31.25%
|
$450,000
$45.0 P/Share
|
|
Sep 10
2019
|
Yi Larson EVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,222
+50.0%
|
$99,990
$45.0 P/Share
|
|
Sep 10
2019
|
Simeon George Director |
BUY
Open market or private purchase
|
Indirect |
177,777
+7.57%
|
$7,999,965
$45.0 P/Share
|